Are cognitive-support products poised to join sexual enhancement, weight loss, and sports performance pills as the next trouble spot for the dietary supplement industry?
It’s a question industry observers are mulling in the wake of a high-profile Federal Trade Commission complaint against ingredient giant DSM, a $5-million class-action lawsuit against best-selling brain booster Prevagen, and allegations by a U.S.
All access premium subscription
This content requires a subscription to Nutrition Business Journal.
As an NBJ subscriber, you receive 10 issues a year and access to the exclusive “NBJ subscriber only” content on newhope.com (excludes three-month subscriptions), which includes PowerPoint presentations, select data charts and archived articles. Subscribers also receive a 10 percent discount on data charts, comprehensive market research reports and webinars.
Email [email protected] for more information about subscribing.